- Home
- SXTP vs SNES Comparison
SXTP vs SNES Comparison
Compare SXTP & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | SNES |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | 24 |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.9M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SXTP | SNES |
|---|---|---|
| Price | $1.16 | $0.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.10 | N/A |
| AVG Volume (30 Days) | ★ 52.4K | 50.3K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 36.77 | ★ 77.99 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,005,471.00 | $600,000.00 |
| Revenue This Year | $33.92 | $29.00 |
| Revenue Next Year | $51.35 | $95.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 65.49 | ★ 132.56 |
| 52 Week Low | $0.34 | $0.70 |
| 52 Week High | $8.62 | $4.65 |
Technical Indicators
Market Signals| Indicator | SXTP | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 18.52 |
| Support Level | $1.05 | N/A |
| Resistance Level | $1.26 | $1.78 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 83.34 | 8.21 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.